investorscraft@gmail.com

Intrinsic Value of ResMed Inc. (RMD)

Previous Close$144.59
Intrinsic Value
Upside potential
Previous Close
$144.59

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2023-06-30 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2023(a)2024202520262027202820292030203120322033203420352036203720382039204020412042204320442045204620472048

INCOME STATEMENT

Revenue growth rate, %18.0NaN
Revenue, $4223NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m3091NaN
Operating income, $m1132NaN
EBITDA, $m1329NaN
Interest expense (income), $mNaN
Earnings before tax, $m1102NaN
Tax expense, $m204NaN
Net income, $m898NaN

BALANCE SHEET

Cash and short-term investments, $m228NaN
Total assets, $m6752NaN
Adjusted assets (=assets-cash), $m6524NaN
Average production assets, $m3321NaN
Working capital, $m1609NaN
Total debt, $m1431NaN
Total liabilities, $m2622NaN
Total equity, $m4130NaN
Debt-to-equity ratio0.347NaN
Adjusted equity ratio0.598NaN

CASH FLOW

Net income, $m898NaN
Depreciation, amort., depletion, $m198NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m693NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-120NaN
Free cash flow, $m813NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m1609
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN

Company description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
HomeMenuAccount